Marboran

Marboran is a Swiss biotechnology company dedicated to the discovery and development of novel antibiotics to address the global threat of multi-drug resistant (MDR) bacterial infections. Founded by a team of experienced pharmaceutical executives, the company focuses on identifying innovative small molecule candidates with unique mechanisms of action, particularly against high-priority Gram-negative pathogens. Marboran aims to fill the critical gap in the antimicrobial pipeline by advancing therapies that can overcome existing resistance mechanisms. The company is headquartered in Geneva and leverages the deep expertise of its founders in the anti-infective space to drive its research programs.